Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOCMSC Study
2017-004123-67Phase 2Active
- Sponsor
- CHRU Nancy
- Start
- Jan 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial in septic shock, bacterial disease and mycoses comparing Mesenchymal stem cells with Control (standard of care) (2 arms). Started Jan 2018; status: active.
02
Drugs
mesenchymal stem cells
03
Conditions
septic shockbacterial diseasemycoses
Beyond the preview
Go deeper on 2017-004123-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004123-67.